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Abstract
 
T helper cell (Th)1-primed CD4 T cells from wild-type donors make little interleukin (IL)-4
when restimulated under Th2 conditions. However, such restimulation of Th1-primed cells
from interferon (IFN)-
 
 
 
 
 
/
 
 
 
 or IFN-
 
 
 
 receptor (IFN-
 
 
 
R)
 
 
 
/
 
 
 
 mice resulted in substantial pro-
duction of IL-4 and other Th2 cytokines. Adding IFN-
 
 
 
 to the priming culture markedly di-
minished the capacity of Th1-primed IFN-
 
 
 
 
 
/
 
 
 
 cells to express IL-4. Even IFN-
 
 
 
–producing
cells from IFN-
 
 
 
R
 
 
 
/
 
 
 
 mice could acquire IL-4–producing capacity. Thus, IFN-
 
 
 
 is not re-
quired for the development of IFN-
 
 
 
–producing capacity, but it plays a critical role in sup-
pressing the IL-4–producing potential of Th1 cells.
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Introduction
 
Undesired immune responses mediated by polarized Th
cells often mediate autoimmune, allergic, and infectious
diseases (1). Altering the cytokine-producing potential of
polarized Th cells has been proposed as a potential thera-
peutic intervention for many of these diseases. However,
the phenotype of polarized Th cells is generally difficult to
alter. In particular, well-polarized Th1 cells fail to produce
IL-4 even after restimulation under Th2-polarizing condi-
tions; such stability is seen for periods of months to years
after initial priming (2–5). Understanding the factors that
contribute to the inability of Th1 cells to express IL-4 may
provide approaches to overcome this barrier.
Th1 and Th2 polarization in vitro have been well char-
acterized. When TCRs of naive CD4
 
 
 
 T cells are first en-
gaged, IL-4 is the major determinant of differentiation of
these cells into Th2 cells (6–9). IL-4 mediates its functions
through binding to and stimulating the IL-4 receptor (IL-
4R). Upon interaction with IL-4, the IL-4R
 
 
 
 and 
 
 
 
c-asso-
ciated kinases, Janus kinase (Jak)
 
*
 
1 and Jak3, are activated
(10, 11). Activated Jak1 and Jak3 then phosphorylate signal
transducer and activator of transcription (STAT)6, which is
essential for initiating IL-4–induced gene transcription and
Th2 polarization (12).
Two STAT6-dependent, Th2-specific transcription fac-
tors, GATA3 and c-maf, have been cloned (13, 14).
GATA3 is expressed at low levels in naive CD4 T cells; its
expression is greatly enhanced 2 d after initial priming in
the presence of IL-4 and is suppressed in Th1 cells. Over-
expression of GATA3 in naive CD4 T cells causes Th2 dif-
ferentiation even in the absence of IL-4. However, it is not
clear whether ectopic expression of GATA3 in committed
Th1 cells is sufficient to induce competence to produce IL-4
(15, 16). c-maf expression is induced by IL-4 and antigen
treatment. Once CD4 cells have been polarized to the Th2
phenotype, c-maf can be rapidly induced by antigen stimu-
lation alone. Experiments using transgenic and gene target-
ing technologies have confirmed that c-maf is an important
regulator of Th2 cell differentiation (17, 18).
IL-12 is a key regulator for directing differentiation of
naive CD4 T cells to the Th1 phenotype (19, 20). IL-12
mediates its functions by binding to IL-12R
 
 
 
1 and 
 
 
 
2
chains. IL-12R
 
 
 
2 is expressed at low levels in naive CD4
T cells; its expression can be upregulated by IFN-
 
 
 
, IL-12,
and antigen stimulation (21, 22). Binding of IL-12 to its re-
ceptors activates Jak2 and Tyk2, leading to STAT4 activa-
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tion. Activated STAT4 can induce IFN-
 
 
 
 expression
by inducing STAT4-dependent, Th1-specific transcription
factor(s), including T-bet (23). The
 
 
 
in vivo role of IL-12,
IL-12 receptors, and STAT4 in Th1 cell differentiation has
been confirmed by genetic targeting experiments (24–26).
IFN-
 
 
 
 has been reported to play an indirect role in Th1
cell differentiation. It upregulates IL-12R
 
 
 
2 chain expres-
sion in naive CD4
 
 
 
 T cells and enhances IL-12 production
by activated macrophages (27). The direct action of IFN-
 
 
 
in Th1 cell differentiation has not been clearly docu-
mented (28).
Here we report that although IFN-
 
 
 
 
 
/
 
 
 
 and IFN-
 
 
 
 re-
ceptor (IFN-
 
 
 
R)
 
 
 
/
 
 
 
 naive CD4
 
 
 
 T cells appear to differen-
tiate into Th1 cells in the presence of IL-12 and anti–IL-4,
they retain the potential to express IL-4 if restimulated in the
presence of IL-4. Our study strongly suggests that IFN-
 
 
 
 is
essential for completion or stabilization of Th1 polarization.
 
Materials and Methods
 
Animals and Cell Cultures.
 
C57Bl/6, IFN-
 
 
 
 knockout (IFN-
 
 
 
 
 
/
 
 
 
), or IFN-
 
 
 
R knockout (IFN-
 
 
 
R
 
 
 
/
 
 
 
) mice (on 129 
 
 
 
C57Bl/6 background) were purchased from The Jackson Labora-
tory. Lymph node cells were depleted of CD8
 
 
 
, B220
 
 
 
, and IA
 
b
 
 
 
cells by negative selection using magnetic beads. The purified
CD4 cells were then centrifuged on a discontinuous 50, 60, and
70% Percoll gradient. Cells with a density of 
 
 
 
70% Percoll were
collected and used for priming (29). Primary stimulation of CD4
T cells was carried out by culturing 10
 
6
 
 CD4 T cells in the pres-
ence of 10
 
7 
 
irradiated T cell–depleted spleen cells from
C57Bl/6, IFN-
 
 
 
 
 
/
 
 
 
, or IFN-
 
 
 
R
 
 
 
/
 
 
 
 mice with anti-CD3 (3 
 
 
 
g/
ml 2C11), 3 
 
 
 
g/ml anti-CD28, and 10 U/ml IL-2 for 7 d. For
differentiation of Th1 cells (Th1-inducing conditions), mono-
clonal anti–IL-4 antibody (10 
 
 
 
g/ml 11B11) and 10 ng/ml IL-12
(R&D Systems) were also added to the culture; for differentiation
of Th2 cells (Th2-inducing conditions), 5 ng/ml IL-4 (BD
PharMingen) and anti–IL-12 antibody (10 
 
 
 
g/ml C17.8) were
added. Th1 cells were primed two or three times before switch-
ing to Th2-inducing conditions.
For single cell cloning experiments, naive CD4 T cells were
deposited at one cell per well into a 96-well plate. Cells were cul-
tured for 2 wk under Th1-inducing conditions. Clones were
screened for IFN-
 
 
 
 production by ELISA. IFN-
 
 
 
–producing
clones were divided into two portions; one was cultured under
Th1-inducing conditions and the other under Th2-inducing
conditions for 1 wk. They were then assayed for IFN-
 
 
 
 or IL-4
by ELISA, RNase protection assay (RPA), or intracellular stain-
ing. Clones that produced 
 
 
 
450 pg/ml of IFN-
 
 
 
 were consid-
ered IFN-
 
 
 
 producing; clones that produced 
 
 
 
300 pg/ml of IL-4
were considered IL-4 producing.
 
Intracellular Staining.
 
Primed cells were stimulated with PMA
and ionomycin in the presence of 2 
 
 
 
M monensin (Calbiochem).
After 6 h of stimulation, cells were treated with 20 
 
 
 
g/ml of
DNase 1 (Boehringer) for 5 min at 37
 
 
 
C, washed with cold PBS,
fixed with 4% paraformaldehyde for 5 min at 37°C, washed with
buffer containing 0.1% saponin and 0.1% BSA, and stained with
FITC-labeled anti–IFN-
 
 
 
 and/or PE-labeled anti–IL-4 (11B11)
monoclonal antibody (BD PharMingen). Samples were analyzed
using a FACScan™ (Becton Dickinson).
 
RPA.
 
Total RNA was isolated with the guanidinium
method. Multiple cytokine RNA probes were synthesized with
RiboQuant RNase Protection kit (BD PharMingen) following
the manufacturer’s instructions. GATA3 template was made by
ligating GATA3 PCR product into PCR2.1 Topo vector (Invit-
rogen). Total RNA (2 
 
 
 
g) was hybridized with multiple RNA
probes overnight. These reactions were then treated with DNase-
free RNase. Protected RNA was separated in a 5% acryl-
amine gel.
 
Affinity Matrix Assay and ELISA.
 
To detect living IFN-
 
 
 
–secret-
ing cells, cells were stimulated with immobilized anti-CD3 and
anti-CD28 for 3 d. The treated cells were then incubated with a
capture antibody (dual specific against CD45 and IFN-
 
 
 
; Mil-
tenyi Biotec) for 5 min on ice. Stained cells were allowed to secrete
IFN-
 
 
 
 at 37
 
 
 
C for 30–45 min before staining with the detection
antibody (PE-conjugated anti–IFN-
 
 
 
; Miltenyi Biotec). For cap-
ture and intracellular double staining, FITC-labeled anti–IFN-
 
 
 
antibodies (BD PharMingen) were incubated in the presence or
absence of saponin with cells that were stained with capture anti-
body. IFN-
 
 
 
–positive cells were sorted by a FACStar™ (Becton
Dickinson). Sorted IFN-
 
 
 
–secreting cells were further cultured
under either Th1- or Th2-inducing conditions for 7 d. At the
end of cultures, cells were washed extensively and restimulated
with 20 ng/ml PMA and 1 
 
 
 
m ionomycin overnight. IL-4 and
IFN-
 
 
 
 production were measured using commercial ELISA de-
tection kits (Endogen).
 
Results
 
IFN-
 
 
 
 
 
/
 
 
 
 CD4 T Cells Primed under Th1 Conditions Can
Be Stimulated to Produce IL-4.
 
To investigate the role of
IFN-
 
 
 
 in Th1 commitment, we primed IFN-
 
 
 
 
 
/
 
 
 
 CD4 T
cells with anti-CD3, anti-CD28, IL-2, IL-12, and anti–IL-4
in the presence of irradiated T cell–depleted spleen cells
from IFN-
 
 
 
 
 
/
 
  
 
mice as APC (Th1 conditions). This Th1-
priming regimen was carried out for two periods of 7 d.
These cells were then subjected to a third round of stimula-
tion either under the same conditions as the initial two
rounds (1-1) or under Th2 conditions (i.e., in the presence
of IL-4 and anti–IL-12; 1-2). While only 3.5% the IFN-
 
 
 
 
 
/
 
 
 
 cells restimulated under Th1 conditions produced IL-4
upon challenge, 50.2% of those cells that had been restimu-
lated under Th2 conditions did so. By contrast, IL-4 was
produced by only 2.4% of wild-type (WT) cells that had
been primed twice under Th1 conditions and restimulated
under Th2 conditions (Fig. 1).
Addition of IFN-
 
 
 
 during the first two rounds of Th1
priming markedly inhibited the capacity of IFN-
 
 
 
 
 
/
 
 
 
 cells
to acquire IL-4–producing capacity when switched to Th2
conditions (4.4% IL-4 producers; Fig. 1). This supports the
conclusion that the effect of IFN-
 
 
 
 in preventing Th1-
primed cells from acquiring IL-4–producing cell phenotype
is a direct one rather than an indirect one caused by lack of
IFN-  during T cell development. One caveat regarding
experiments in which IFN-  is added to the priming cul-
tures is that cell yields are diminished by the addition of this
cytokine. However, the addition of IFN-  to Th1-inducing
cultures of WT cells or to Th2-inducing cultures of IFN-
  /  cells did not diminish Th1 polarization and diminished
Th2 polarization only moderately. This suggests that dimin-
ished cell yield does not explain the inability of IFN-167 Zhang et al.
  /  cells primed under Th1 conditions, with the addition
of IFN- , to acquire IL-4–producing capacity. Adding
IFN-  to the restimulation culture (i.e., IL-4, anti–IL-12,
and IFN- ) caused a much less striking diminution in the
frequency of IFN-  /  cells that produced IL-4 (to 36.2%).
To further determine whether the presence of IFN-  is
only required early in the priming period to suppress IL-4–
producing potential in Th1 cells, naive CD4 T cells were
primed under Th1 conditions and then switched to Th2
conditions in the presence or absence of anti-IFN-  anti-
body. Th1 cells that were switched in the presence of anti–
IFN-  failed to produce detectable IL-4 as measured by
ELISA. The amount of IFN-  produced by “switched”
Th1 cells was reduced 4–5-fold compared with cells re-
stimulated in IL-12 plus anti–IL-4 (Fig. 2). Collectively,
these data indicate that suppression of IL-4–producing po-
tential by IFN-  is determined early in priming phase and
is thereafter independent of IFN- .
Switched IFN-  /  Cells Express mRNA for Th2 Cyto-
kines. IFN-  /  CD4 T cells were subjected to three
rounds of Th1 priming and then switched to Th2 condi-
tions for an additional round. Upon stimulation, these cells
expressed mRNA for IL-4, IL-5, and IL-13, as detected by
a RPA (Fig. 3). By contrast, WT cells primed for three
rounds under Th1 conditions failed to develop the capacity
to express mRNA for any of these cytokines when restim-
ulated under Th2 conditions.
IFN- R /  Th1 Cells Can Be Switched to Expression of
Th2 Cytokines. Naive CD4 T cells from IFN- R / 
mice were subjected to three rounds of priming under Th1
conditions. When restimulated under Th1 conditions and
Figure 1. IFN-  /  CD4 T cells primed
under Th1 conditions can be restimulated
to acquire IL-4–producing capacity. Naive
CD4 T cells prepared from WT mice and
IFN-  /  mice were cultured under Th1-
or Th2-inducing conditions in the presence
or absence of IFN-  (10 ng/ml) for 7 d.
Priming under Th1-inducing conditions
was repeated once. At the end of the prim-
ing, Th1 cells were washed and further cul-
tured under either Th1-inducing conditions
(1-1) in the presence or absence of IFN- 
or under Th2-inducing conditions (1-2) for
7 d. Th2-primed cells were also restimu-
lated under Th1- (2-1) or Th2- (2-2) in-
ducing conditions. Cells were then washed
and restimulated with PMA and ionomycin
for 6 h. Cytosolic cytokine content was
measured by staining with anti–IFN-  and
anti–IL-4 antibodies.
Figure 2. Maintenance of IL-4 silence in Th1 cells is independent of
IFN- . Naive CD4 T cells from C57Bl6 mice were primed under Th1
conditions for 7 d plus 7 d of resting in IL-2 medium. The resulting cul-
tures were washed and restimulated under Th1 conditions or Th2 condi-
tions in the presence or absence of anti–IFN-  antibody for 7 d. For con-
trol, naive CD4 T cells were primed under Th2 conditions for 7 d. At the
end of culture period, cells were washed extensively and restimulated
with PMA and ionomycin overnight. Supernatants were collected and
measured for IL-4 and IFN-  proteins by ELISA. B.D., below detection.168 IFN-  Stabilizes the Th1 Phenotype
then challenged, they expressed IFN-  mRNA, but no
IL-4, IL-5, or IL-13 mRNA (Fig. 4 A). When analyzed af-
ter two and three rounds of Th1 priming, CD4 T cells
from IFN- R /  mice produced 50 and 70%, respectively,
as much IFN-  as did similarly primed WT cells (Fig. 4 B).
Consistent with previous studies, these data suggest that
IFN-  is not essential for CD4 T cells to acquire IFN- –
producing capacity (28).
Despite their acquisition of IFN- –producing capacity,
Th1-primed IFN- R /  cells could develop into IL-4
producers upon restimulation under Th2 conditions. These
cells expressed IL-4 mRNA and large amounts of IL-5 and
IL-13 mRNA when compared with one round–primed
WT Th2 cells (Fig. 4 A). Thus, cells that are insensitive to
IFN-  can be primed to express IFN-  but retain the ca-
pacity to express Th2 cytokines upon appropriate stimula-
tory conditions. In these experiments, the APCs used were
obtained from WT donors; thus, the effect of IFN-  in
preventing Th1-primed cells from acquiring IL-4–produc-
ing capacity must be on the developing Th1 cells.
Intracellular staining for IL-4 or IFN-  showed that
47.7% of IFN- R /  Th1 cells demonstrated the capacity
to produce IL-4 when stimulated under Th2-inducing
conditions for a week, whereas IFN- –producing capacity
of these cells was diminished markedly (from 40.9 to
14.6%). Conversely, WT Th1 cells even stimulated under
Th2-inducing conditions failed to acquire IL-4-producing
capacity. The percentage of IFN- –producing cells de-
creased only moderately (from 40.7 to 39.6%) after stimula-
tion under Th2-inducing conditions (Fig. 4 C).
To determine whether the capacity to develop into Th1
cells that could be switched was the property of rare or
common naive IFN- R /  CD4 T cells, single dense CD4
T cells from IFN- R /  mice were sorted onto a 96-well
plate. The cells were cultured under Th1-inducing condi-
tions for one round (2 wk), two rounds, or three rounds.
Clones that produced IFN-  were identified by ELISA.
On average, they produced 4.8 ng/ml of IFN-  (range:
0.45–15 ng/ml) and no detectable IL-4. IFN- –producing
clones were divided into two aliquots. One was restimu-
Figure 3. Switched IFN-  / 
Th1 cells can express mRNA for
Th2 cytokines.  Naive CD4 T
cells from C57Bl6 mice and
IFN-  /  mice were incubated
under Th1-inducing conditions
for three rounds of 7 d each. At
the end of third round of differ-
entiation, the cells were further
differentiated under Th1-induc-
ing conditions (1-1) or Th2-
inducing conditions (1-2) for
7 d. Cells were then restimulated
with anti-CD3, anti-CD28, and
irradiated T cell–depleted APCs
for 4 h. Total RNA was ana-
lyzed for cytokine gene expres-
sion by RPA.
Figure 4. Switched IFN- R /  Th1 cells can express Th2 cytokines.
(A) WT and IFN- R /  CD4 T cells were cultured under Th1 condi-
tions for three rounds. For the fourth round, the cells were cultured under
Th1-inducing conditions (1-1) or Th2-inducing conditions (1-2) for 7 d.
As control, naive CD4 T cells were primed under Th2-inducing condi-
tions for 7 d. Cells were restimulated with PMA and ionomycin for 4 h.
Total RNA was analyzed for cytokine gene expression by RPA. (B) Naive
CD4 T cells from WT and IFN- R /  were primed under Th1-inducing
conditions for various rounds of priming (2 , 2 rounds; 3 , 3 rounds).
Cells were stimulated with PMA and ionomycin overnight. IFN-  con-
tent of supernatants was measured by ELISA. (C) Three round–primed
WT and IFN- R /  Th1 cells were cultured under Th1- or Th2-induc-
ing conditions for 1 wk. Cells were challenged with PMA and ionomycin
for 4 h. IL-4 and IFN-  were detected by intracellular staining.169 Zhang et al.
lated under Th1-inducing conditions and the other under
Th2-inducing conditions for 1 wk. At the end of culture
period, cells were washed extensively and restimulated
with PMA and ionomycin. IFN-  and IL-4 expression
were measured by ELISA, intracellular staining, or RPA.
We found that 50, 40, and 50% of IFN- R /  Th1 cell
clones could become IL-4 producers after being primed
under Th1-inducing conditions for one round, two
rounds, and three rounds, respectively. On average, IL-4–
producing clones produced 1.9 ng/ml of IL-4 (range: 0.3–
6.1 ng/ml). Conversely, none of the WT Th1 clones re-
tained the ability to differentiate into Th2 cells, even those
primed just after one round (Fig. 5). Thus, switched IFN-
 R /  IL-4 producers were not the result of the expansion
of rare precommitted Th2 cells that might have been
present in the naive CD4 T cell preparations. These results
indicate that IFN- R /  Th1 cells retain IL-4–producing
potential.
IFN-  Producers from IFN- R /  Mice Retain the Potential
to Develop IL-4–producing Capacity. The previous experi-
ments showed that a cell population that produces IFN- 
can be stimulated to produce IL-4. However, they do not
establish that individual IFN- –producing cells can acquire
the capacity to produce IL-4 upon restimulation under
Th2 conditions. To determine whether such IFN- –pro-
ducing cells could become IL-4 producers, we primed WT
and IFN- R /  naive CD4  T cells under Th1 conditions
with WT APCs for three rounds. IFN-  producers in
those cultures were then purified by the affinity matrix
technology and electronic cell sorting. We stimulated IFN-
 R /  Th1 cells with anti-CD3 and anti-CD28 plus irra-
diated APCs for 3 d. IFN- –secreting cells were stained
with bispecific antibody against CD45 and IFN- , and
then the captured IFN-  was detected with PE-labeled
anti–IFN-  antibody. The authenticity of these IFN- 
producers was confirmed by intracellular staining with an
FITC-labeled, anti–IFN-  antibody (Fig. 6 A). Sorted
IFN-  producers from both IFN- R /  and WT donors
were restimulated under either Th1 or Th2 conditions
with WT APCs. IFN-  producers from the IFN- R / 
donors produced IL-4 after Th2 restimulation, whereas
WT IFN-  producers did not (Fig. 6, B and C). The
amount of IL-4 produced per 106 switched IFN- R / 
Figure 5. IFN- R /  Th1 cell clones retain the capacity to become IL-4
producers. Single dense naive CD4 T cells from WT and IFN- R / 
mice were automatically deposited into a 96-well plate. Cells were further
cultured for the time periods indicated under Th1-inducing conditions.
Clones were assayed for IFN-  production and divided into cultures un-
der Th1- or Th2-inducing conditions for 1 wk. At the end of culture, cells
were washed and restimulated with PMA and ionomycin. Supernatants
were measured for IFN-  and IL-4 production by ELISA. Data were rep-
resentative of two independent experiments.
Figure 6. IFN-  producers from Th1-primed IFN- R /  cells can
produce IL-4. (A) IFN- R /  Th1 cells were stimulated with anti-CD3
and anti-CD28 for 3 d. IFN- –producing cells were detected by affinity
matrix assay (IFN- –PE). Cells were double stained with FITC-labeled
anti-CD4 (CD4–FITC) or FITC-labeled anti–IFN-  antibody (IFN- –
FITC) in the presence or absence of saponin. (B) Three round–primed
WT and IFN- R /  Th1 cells were stimulated with anti-CD3 and anti-
CD28 for 3 d. IFN- –secreting cells were detected by the affinity matrix
assay. IFN-   cells were purified by a FACStar™. Purity for WT and
IFN- R /  IFN-   cells were 99 and 96%, respectively. (C) Purified WT
and IFN- R /  IFN-  producers were restimulated under Th1-inducing
conditions or Th2-inducing conditions for 7 d. Cells were then washed ex-
tensively and stimulated with PMA and ionomycin at 106 cells per milliliter
density. IL-4 content of supernatants was measured by ELISA.170 IFN-  Stabilizes the Th1 Phenotype
cells was  1/2 that made by a comparable number of one
round–primed Th2 cells from WT donors.
Induction of GATA3 mRNA Is Enhanced in IFN- R / 
Th1 Cells. To study possible mechanism(s) by which
IFN-  silences Th2 cytokine gene transcription in com-
mitted Th1 cells, we measured GATA3 mRNA levels in
Th1-primed IFN- R /   and WT cells that had been
primed under Th1 conditions for three rounds and then re-
stimulated under Th2 conditions. The IFN- R /  Th1
cells showed dramatic upregulation of GATA3 mRNA ex-
pression when exposed to Th2-inducing conditions for 48 h
(data not shown) and 7 d (Fig. 7), as measured by RPA,
while similarly treated WT cells failed to express GATA3
mRNA. These data suggest that IFN-  represses the
GATA3 transcription that normally occurs in response to
IL-4 stimulation.
Discussion
Our data indicate that development of IFN- –produc-
ing capacity of naive T cells and the suppression of the po-
tential to acquire IL-4–producing activity are two separate
events in the development of a polarized Th1 phenotype.
In the presence of IL-12 and appropriate TCR signals, na-
ive CD4 T cells can develop IFN- –producing capacity.
This process is STAT4 dependent (26). Regulation of IL-
12R 2 chain expression by IFN- , IL-12, and antigen
stimulation also contribute to the polarization of Th1 cells
(21, 22). However, IL-12 alone is not sufficient to suppress
the IL-4–producing potential of cells that produce IFN- .
The IFN- –producing cells from the IFN- R /  donors
retained the capacity to develop into IL-4 producers even
after three or more rounds of priming in the presence of
IL-12.
The suppressive effect of IFN-  on the IL-4–producing
potential of Th1 cells appears to be a direct effect rather
than a reflection of developmental abnormalities due to
lack of IFN-  or IFN-  responsiveness. Addition of IFN- 
to IFN-  /  Th1 cell cultures during the initial Th1 prim-
ing period suppressed the ability of IFN-  Th1 cells to ac-
quire IL-4–producing capacity. Furthermore, the immune
systems of IFN-  /  and IFN- R /  mice appear to de-
velop normally (30, 31).
IFN- –mediated suppression of IL-4–producing poten-
tial appears to occur principally during the initial priming
phase. This result is consistent with previous reports that
demonstrated IFN- R  chain was downregulated in dif-
ferentiated Th1 cells that would result in insensitivity to
IFN-  (32, 33). Furthermore, addition of anti–IFN-  anti-
body to one round–primed WT Th1 cells that were re-
stimulated under Th2 conditions failed to develop IL-4–
producing capacity. Thus, these data indicate that once
IFN-  exerts its effects on suppressing the IL-4–producing
potential in the initial priming, it is no longer required to
maintain IL-4 “silencing.”
It has previously been concluded that a key factor in sta-
bilizing Th1 phenotype was the absence of IL-4. Naka-
mura et. al. (34) reported that even in the presence of anti–
IL-4 antibody, Th1 cells that were primed twice could
retain the ability to respond to IL-4 with upregulated
CD30 expression and 90 U/ml of IL-5, whereas similarly
primed IL-4 /  Th1 cells lost this IL-4 responsiveness. Our
data demonstrate that priming naive WT CD4 T cells in
the presence of IL-12 and anti–IL-4 results in a cell popula-
tion that cannot acquire the capacity to produce IL-4, IL-5,
or IL-13 even if restimulated in the presence of anti–IL-12
and IL-4. The presence of small amounts of IL-4 during
the priming period might allow “Th1” cells to switch or
might prime a population of cells to differentiate partially
along the Th2 pathway so that the switching culture could
complete such differentiation. In any case, the inability of
the cells that we have primed in the presence of IL-12 and
anti–IL-4 suggests that the concentration of anti–IL-4 we
have used is sufficient to completely neutralize IL-4 and
thus to reveal the critical role IFN-  plays in stabilization of
the Th1 phenotype.
How does IFN-  mediate its suppressive effects on IL-4–
producing potential in WT Th1 cells? Inhibition of IL-4–
induced GATA3 transcription appears to be one key
mechanism by which IFN-  suppresses the potential of
CD4 T cells to acquire IL-4–producing capacity and thus
maintains a stable Th1 phenotype. IFN-  may suppress
GATA3 transcription through mechanism(s) not involving
suppressor of cytokine signaling (SOCS)1–3. It has been
reported that overexpression of SOCS1, but not SOCS2,
can suppress STAT6 functions in B cells (35). Similar find-
ings in human monocytes and hepatocytes were also re-
ported (36). SOCS1 is rapidly induced by IFN-  treat-
ment. Surprisingly, we found that IFN- R /  Th1 cells
expressed the same amount of SOCS1–3 mRNA as WT
Th1 cells (data not shown).
Our study raises the question of how to define the Th1
phenotype. Simple capacity to produce IFN-  may not be
sufficient, since it has been shown that well-polarized Th2
cells can develop IFN- –producing capacity if restimulated
in the presence of anti–IL-4 and IL-12 (5). Thus, one
might require that Th1 cells both have the capacity to pro-
duce IFN-  and have lost the capacity to become IL-4
producers. On the other hand, one could argue that the ac-
quisition of IFN- –producing capacity by nonIL-4 pro-
ducers marks acquisition of a Th1 phenotype, and inability
to switch to IL-4 production denotes stabilization of that
phenotype. Recently, Grogan et. al. (37) have reported
Figure 7. Induction of GATA3 is enhanced in IFN- R /  Th1 cells.
Three round Th1-primed WT and IFN- R /  cells were further differ-
entiated under either Th1- or Th2-inducing conditions for 7 d. Total
RNA (2  g) was used to detect GATA3 mRNA by RPA.171 Zhang et al.
that the IL-4 gene is found in centromeric heterochroma-
tin in Th1 cells but not in naive or Th2 cells. This suggests
that silencing of the IL-4 gene is an active process during
Th1 differentiation. The capacity of cells that have been
primed under Th1 conditions but did not receive an IFN- 
signal to retain the potential to activate the IL-4 gene sug-
gests that such silencing has not occurred and that IFN- 
may play a role in the silencing process.
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